XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $136,000 | -9.9% | 33,440 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $151,000 | -8.5% | 33,440 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $165,000 | -16.7% | 33,440 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $198,000 | +187.0% | 33,440 | +28.4% | 0.00% | – |
| Q2 2020 | $69,000 | +35.3% | 26,036 | 0.0% | 0.00% | – |
| Q1 2020 | $51,000 | -64.8% | 26,036 | +26.7% | 0.00% | -100.0% |
| Q4 2019 | $145,000 | -13.2% | 20,543 | +20.8% | 0.00% | 0.0% |
| Q3 2019 | $167,000 | -1.2% | 17,003 | +15.3% | 0.00% | 0.0% |
| Q2 2019 | $169,000 | +14.2% | 14,741 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $148,000 | – | 14,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $14,901,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,553,398 | $26,672,000 | 0.47% |
| Alpine Global Management, LLC | 354,524 | $1,443,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 275,500 | $1,121,000 | 0.15% |
| Kamunting Street Capital Management, L.P. | 67,594 | $275,000 | 0.11% |
| IHT Wealth Management, LLC | 340,147 | $1,384,000 | 0.09% |
| Redmile Group, LLC | 1,358,825 | $5,530,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 173,318 | $705,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,815,091 | $7,387,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 49,025 | $200,000 | 0.05% |